Pathobiology of Ischemic Heart Disease: Past, Present and Future
- PMID: 26897485
- DOI: 10.1016/j.carpath.2016.01.007
Pathobiology of Ischemic Heart Disease: Past, Present and Future
Abstract
This review provides a perspective on knowledge of ischemic heart disease (IHD) obtained from the contemporary era of research which began in the 1960s and has continued to the present day. Important discoveries have been made by basic and translational scientists and clinicians. Pathologists have contributed significantly to insights obtained from experimental studies and clinicopathological studies in humans. The review also provides a perspective for future directions in research in IHD aimed at increasing basic knowledge and developing additional therapeutic options for patients with IHD.
Keywords: Hibernation; Mitochondria; Myocardial infarction; Myocardial ischemia; Postconditioning; Preconditioning; Stunning.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
[Three cardiac mysteries--stunning, hibernation and ischemic preconditioning].Tidsskr Nor Laegeforen. 2001 Feb 10;121(4):440-4. Tidsskr Nor Laegeforen. 2001. PMID: 11255859 Review. Norwegian.
-
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29. Pharmacol Rev. 2007. PMID: 18048761 Review.
-
[Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia].Schweiz Med Wochenschr. 1997 Nov 29;127(48):2008-13. Schweiz Med Wochenschr. 1997. PMID: 9490468 Review. German.
-
Pathophysiology of hibernation, stunning, and ischemic preconditioning.Thorac Cardiovasc Surg. 1998 Sep;46 Suppl 2:255-62; discussion 263. doi: 10.1055/s-2007-1013082. Thorac Cardiovasc Surg. 1998. PMID: 9822176 Review.
-
Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):260-6. doi: 10.1177/1074248411415270. J Cardiovasc Pharmacol Ther. 2011. PMID: 21821526 Review.
Cited by
-
Enterobacterales Biofilm-Specific Genes and Antimicrobial and Anti-Inflammatory Biomarkers in the Blood of Patients with Ischemic Heart Disease.Diagnostics (Basel). 2024 Mar 5;14(5):546. doi: 10.3390/diagnostics14050546. Diagnostics (Basel). 2024. PMID: 38473018 Free PMC article.
-
Protective effects of Shen Yuan Dan on myocardial ischemia-reperfusion injury via the regulation of mitochondrial quality control.Cardiovasc Diagn Ther. 2023 Apr 28;13(2):395-407. doi: 10.21037/cdt-23-86. Epub 2023 Apr 24. Cardiovasc Diagn Ther. 2023. PMID: 37583687 Free PMC article.
-
Growth factor for therapeutic angiogenesis in ischemic heart disease: A meta-analysis of randomized controlled trials.Front Cell Dev Biol. 2022 Dec 9;10:1095623. doi: 10.3389/fcell.2022.1095623. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36568984 Free PMC article. Review.
-
Clinicopathological correlations in heart transplantation recipients complicated by death or re-transplantation.Front Cardiovasc Med. 2022 Nov 3;9:1014796. doi: 10.3389/fcvm.2022.1014796. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36407445 Free PMC article.
-
Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia.Mil Med Res. 2021 Nov 10;8(1):58. doi: 10.1186/s40779-021-00353-0. Mil Med Res. 2021. PMID: 34753510 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
